Medical Affairs Lead

Opportunity summary

Location: Cambridge, MA or Copenhagen, DenmarkReporting to: VP Medical AffairsAbout HemabHemab is building preventative treatments for serious, underserved bleeding disorders. These are therapies designed to work with the body's own biology and stop bleeds before they start, instead of treating them after they happen. Our pipeline spans more than one mechanism and modality, because the patients we're built for don't all fit the same one. Many of the conditions we work on affect women's health specifically, and they've gone overlooked for far longer than they should have - we're a patient-first, science-led, clinical-stage company.We went public via our 2026 IPO, and we're scaling across two homes: Cambridge, MA and Copenhagen, Denmark.The roleThis role owns end-to-end medical strategy for one or more Hemab pipeline assets, spanning Glanzmann thrombasthenia, von Willebrand disease, Factor VII deficiency, or heavy menstrual bleeding. You'll translate the biology of the coagulation cascade into the medical narrative that shapes how clinicians, investigators, payers, and patients understand the disease, and carry an asset's evidence and engagement plan from late-sta1 …

This is a shortened extract from the public vacancy. Follow the original posting for the complete and authoritative description.